Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ELVN

Enliven Therapeutics, Inc.

CIK 0001672619 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$59.82
↑ 0.90 (1.53%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$4.38B
P/E Ratio
-41.38
EPS
-1.83
Dividend Yield
Not covered
52W Position
95%
Beta
1.00

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.90
P/S
Not covered
EV/Revenue
Not covered
ROE
-11.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 95%
$14.79$62.32

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$103.69M
Total Assets
$476.17M
Free Cash Flow
–

Recent news